Covid Inquiry Phase 2 documents

A Goodwin made this Official Information request to Ministry of Health

The request was successful.

From: A Goodwin

Dear Ministry of Health,

1) At paragraph 310 of the Covid Inquiry Phase 2 report, it is noted that Medsafe recommended a plan to strengthen existing arrangements to monitor COVID-19 vaccine safety. Please provide details of this plan including the document mentioned at footnote 289 – “A COVID-19 Vaccine Safety Surveillance Strategy for New Zealand: Framework Proposal for Discussion, New Zealand Pharmacovigilance Centre – University of Otago (28 September 2020)”

2) In reference to paragraph 304 of the Covid Inquiry Phase 2 report, please provide the list of ‘critical terms’ compiled by CARM/Medsafe assessors that they considered should trigger an adverse event report to be reviewed.

Yours faithfully,

A Goodwin

Link to this

From: OIA Requests

Kia ora, 

The Ministry of Health is taking a short break over Easter from 3 April to
7 April 2026. During this time this inbox will not be monitored. We will
endeavor to respond to your email upon our return.

Have a safe and happy Easter weekend.
OIA Services Team
Ministry of Health | Manatū Hauora

show quoted sections

Link to this

From: OIA Requests


Attachment image.png
25K Download


Kia ora A Goodwin,

 

Thank you for your request under the Official Information Act 1982 (the
Act), received by the Ministry of Health - Manatû Hauora on 6 April 2026
You requested:

 

"1) At paragraph 310 of the Covid Inquiry Phase 2 report, it is noted that
Medsafe recommended a plan to strengthen existing arrangements to monitor
COVID-19 vaccine safety.  Please provide details of this plan including
the document mentioned at footnote 289 – ‘A COVID-19 Vaccine Safety
Surveillance Strategy for New Zealand: Framework Proposal for Discussion,
New Zealand Pharmacovigilance Centre – University of Otago (28 September
2020)’

 

2) In reference to paragraph 304 of the Covid Inquiry Phase 2 report,
please provide the list of ‘critical terms’ compiled by CARM/Medsafe
assessors that they considered should trigger an adverse event report to
be reviewed."
 

The reference number for your request is H2026081053. We will endeavour to
respond to your request as soon as possible and in any event no later than
5 May 2026 being 20 working days after the day your request was received.
If we are unable to respond to your request by then, we will notify you of
an extension of that timeframe.

 

If you have any queries regarding your request, please feel free to
contact the OIA Services Team on [1][email address]. If any
additional factors come to light which are relevant to your request,
please do not hesitate to contact us so that these can be taken into
account. 

 

Under section 28(3) of the Act you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [2][email address] or by calling 0800
802 602.

 

 

Ngâ mihi, 
 
OIA Services Team

Ministry of Health | Manatû Hauora

 

M[3]inistry of Health information releases

show quoted sections

References

Visible links
1. mailto:[email address]
mailto:[email address]
2. mailto:[email address]
mailto:[email address]
3. https://www.health.govt.nz/about-ministr...
https://www.health.govt.nz/about-ministr...

Link to this

From: OIA Requests


Attachment Outlook bdufb3bl.png
20K Download

Attachment H2026081053 response.pdf
228K Download View as HTML

Attachment H2026081053 Appendix 1 COVID 19 vaccine safety surveillance strategy Sep 2020.pdf
1.8M Download View as HTML


Kia ora, 
 
Please find attached the response for your request for official
information.
Ngā mihi,

OIA Services Team

Ministry of Health | Manatū Hauora

show quoted sections

Link to this

Things to do with this request

Anyone:
Ministry of Health only: